Are Topical Nonsteroidal Anti-inflammatory Drugs Effective on Cataract Surgery Outcome in Pseudoexfoliation Syndrom? - International Journal of Medical Investigation

[Home ] [Archive]

International Journal of Medical Investigation

awt-yekta

Editorial Board

Submit an article

Main Menu

Home

Journal Information

Articles archive

For Authors

For Reviewers

Registration

Site Facilities

Editorial Board

Search in website

Receive site information

Volume 10, Issue 4 (12-2021)

Int J Med Invest 2021, 10(4): 50-61

Back to browse issues page

Are Topical Nonsteroidal Anti-inflammatory Drugs Effective on Cataract Surgery Outcome in Pseudoexfoliation Syndrom?

Mitra Akbari ^*

, Reza Soltani Moghadam

, Anvar Mohamadpour

Eye Research Center, Department of Eye, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Science, Rasht, Iran

Abstract: (2111 Views)

Purpose: Patients with pseudo-exfoliation syndrome (PEX) have a higher risk of inflammation after phacoemulsification surgery that can result in several complications in anterior and posterior segments. The present study aimed to evaluate the effect of adding topical ketorolac to steroids on anterior segment inflammation and complications.
Methods: In this randomized clinical trial, 88 patients with cataract and PEX, candidate of phacoemulsification surgery, were randomized to receive either 5% chloramphenicol + 0.1% betamethasone with or without 0.5% ketorolac tromethamine eye drops for two weeks. Anterior chamber inflammation (ACI), intraocular pressure (IOP), and best corrected visual acuity (BCVA) were recorded 1, 3, 7, and 30 days after surgery and the degree of opacity of the anterior capsule (ACO) and opacity of the posterior capsule (PCO) six months after surgery were compared between the two groups using SPSS v.21.
Results: Forty-six patients were evaluated in ketorolac group and 42 in the control (without ketorolac). IOP and BCVA were not different between two groups on days 1, 3, 7, and 30 after surgery (P>0.05). However, the group using ketorolac had less ACI on days 3, 7, and 30 after surgery (P<0.05) and lower degrees of ACO and PCO six months after surgery (P<0.05).
Conclusion: Addition of ketorolac eye drop to steroid eye drop after cataract surgery had additional effect on reducing ACI after cataract surgery in patients with cataract and PEX with additional effect on reducing ACO, and PCO.

Keywords: Cataract, Ketorolac, Exfoliation Syndrome

Full-Text [PDF 282 kb] (507 Downloads)

Type of Study: Research | Subject: General

References

1. 1. Khairallah M, Kahloun R, Bourne R, Limburg H, Flaxman SR, Jonas JB, et al. Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010. Investigative ophthalmology & visual science. 2015;56(11):6762-9. 2. Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. The lancet global health. 2013;1(6):e339-e49. 3. Davis G. The evolution of cataract surgery. Missouri medicine. 2016;113(1):58. 4. Lam D, Rao SK, Ratra V, Liu Y, Mitchell P, King J, et al. Cataract. Nature reviews Disease primers. 2015;1(1):1-15. 5. Stein JD. Serious adverse events after cataract surgery. Current opinion in ophthalmology. 2012;23(3):219. 6. Chan E, Mahroo OA, Spalton DJ. Complications of cataract surgery. Clinical and Experimental Optometry. 2010;93(6):379-89. 7. Fontana L, Coassin M, Iovieno A, Moramarco A, Cimino L. Cataract surgery in patients with pseudoex-foliation syndrome: current updates. Clinical Ophthalmology (Auckland, NZ). 2017;11:1377. 8. Sangal N, Chen TC, editors. Cataract surgery in pseudoexfoliation syndrome. Seminars in ophthalmology; 2014: Taylor & Francis. 9. Sufi AR, Singh T, Mufti AA, Rather MH. Outcome of phacoemulsification in patients with and without pseudoexfoliation syndrome in Kashmir. BMC ophthalmology. 2012;12(1):1-5. 10. Vazquez-Ferreiro P, Carrera-Hueso FJ, Jornet JEP, Fikri-Benbrahim N, Diaz-Rey M, Sanjuan-Cerveró R. Intraoperative complications of phacoemulsification in pseudoexfoliation: Metaanalysis. Journal of Cataract & Refractive Surgery. 2016;42(11):1666-75. 11. DwiveDi NR, Dubey AK, ShaNKaR PR. Intraoperative and immediate postoperative outcomes of cataract surgery using phacoemulsification in eyes with and without pseudoexfoliation syndrome. Journal of clinical and diagnostic research: JCDR. 2014;8(12):VC01. 12. Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915-24. 13. Akbari M, Moghadam RS, Elmi R, Nosrati A, Taghiabadi E, Aghdami N. Adjunctive Tacrolimus for Herpetic Stromal Keratitis. J Ophthalmic Vis Res 2019;14:400–411. 14. Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, et al. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome. Journal of Cataract & Refractive Surgery. 2016;42(8):1119-25. 15. Group SoUNW. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American journal of ophthalmology. 2005;140(3):509-16. 16. Raj SM, Vasavada AR, Johar SK, Vasavada VA, Vasavada VA. Post-operative capsular opacification: a review. International journal of biomedical science: IJBS. 2007;3(4):237. 17. Sastry PV, Singal AK. Cataract surgery outcome in patients with non-glaucomatous pseudoexfoliation. Romanian journal of ophthalmology. 2017;61(3):196. 18. Pranathi K, Magdum RM, Maheshgauri R, Patel K, Patra S. A study of complications during cataract surgery in patients with pseudoexfoliation syndrome. Journal of Clinical Ophthalmology and Research. 2014;2(1):7. 19. Hoffman RS, Braga-Mele R, Donaldson K, Emerick G, Henderson B, Kahook M, et al. Cataract surgery and nonsteroidal antiinflammatory drugs. Journal of Cataract & Refractive Surgery. 2016;42(9):1368-79. 20. Seol BR, Shin JY, Choi S, Kang TG, Jeoung JW, Park KH. Intraocular pressure (IOP) change and frequency of IOP spike after cataract surgery in normal-tension glaucoma: a case-control study. Journal of glaucoma. 2019;28(3):201-6. 21. Kristianslund O, Østern AE, Råen M, Sandvik GF, Drolsum L. Does cataract surgery reduce the long‐term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta ophthalmologica. 2016;94(3):261-5. 22. Vahedian Z, Salmanroghani R, Fakhraie G, Moghimi S, Eslami Y, Zarei R, et al. Pseudoexfoliation syndrome: Effect of phacoemulsification on intraocular pressure and its diurnal variation. Journal of current ophthalmology. 2015;27(1-2):12-5. 23. Wormstone I, Wormstone Y, Smith A, Eldred J. Posterior capsule opacification: What's in the bag? Progress in Retinal and Eye Research. 2020:100905. 24. Hecht I, Karesvuo P, Achiron A, Elbaz U, Laine I, Tuuminen R. Anti-inflammatory medication after cataract surgery and posterior capsular opacification. American journal of ophthalmology. 2020;215:104-11. 25. Sufi AR, Mufti AA, Nazir N, Qureshi T, Ramzan R. Prevalence of pseudoexfoliation syndrome in patients scheduled for cataract surgery in eye camps in Kashmir. Journal of Clinical Ophthalmology and Research. 2014;2(3):137. 26. Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. American journal of ophthalmology. 2010;149(5):777-84. 27. Sahu S, Ram J, Bansal R, Pandav SS, Gupta A. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract & Refractive Surgery. 2015;41(10):2043-8.

Add your comments about this article

‎ 20.1001.1.23222913.2021.10.4.9.9

XML

Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbari M, Moghadam R S, Mohamadpour A. Are Topical Nonsteroidal Anti-inflammatory Drugs Effective on Cataract Surgery Outcome in Pseudoexfoliation Syndrom?. Int J Med Invest 2021; 10 (4) :50-61
URL: http://intjmi.com/article-1-683-en.html

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Volume 10, Issue 4 (12-2021)

Back to browse issues page

International Journal of Medical Investigation

Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4660